BACKGROUND: Cigarette smoking is an established risk factor for adult myeloid leukemia, particularly acute myeloid leukemia (AML), but less is known about the nature of this association and effects of smoking cessation on risk. METHODS: In a large population-based case-control study of myeloid leukemia that included 414 AML and 185 chronic myeloid leukemia (CML) cases and 692 controls ages 20-79 years, we evaluated risk associated with cigarette smoking and smoking cessation using unconditional logistic regression methods and cubic spline modeling. RESULTS: AML and CML risk increased with increasing cigarette smoking intensity in men and women. A monotonic decrease in AML risk was observed with increasing time since quitting, whereas for CML, the risk reduction was more gradual. For both AML and CML, among long-term quitters (≥30 years), risk was comparable to non-smokers. CONCLUSIONS: Our study confirms the increased risk of myeloid leukemia with cigarette smoking and provides encouraging evidence of risk attenuation following cessation.
BACKGROUND: Cigarette smoking is an established risk factor for adult myeloid leukemia, particularly acute myeloid leukemia (AML), but less is known about the nature of this association and effects of smoking cessation on risk. METHODS: In a large population-based case-control study of myeloid leukemia that included 414 AML and 185 chronic myeloid leukemia (CML) cases and 692 controls ages 20-79 years, we evaluated risk associated with cigarette smoking and smoking cessation using unconditional logistic regression methods and cubic spline modeling. RESULTS:AML and CML risk increased with increasing cigarette smoking intensity in men and women. A monotonic decrease in AML risk was observed with increasing time since quitting, whereas for CML, the risk reduction was more gradual. For both AML and CML, among long-term quitters (≥30 years), risk was comparable to non-smokers. CONCLUSIONS: Our study confirms the increased risk of myeloid leukemia with cigarette smoking and provides encouraging evidence of risk attenuation following cessation.
Authors: Devon Alton; Lawson Eng; Lin Lu; Yuyao Song; Jie Su; Delaram Farzanfar; Rahul Mohan; Olivia Krys; Katie Mattina; Christopher Harper; Sophia Liu; Tom Yoannidis; Robin Milne; M Catherine Brown; Ashlee Vennettilli; Andrew J Hope; Doris Howell; Jennifer M Jones; Peter Selby; Wei Xu; David P Goldstein; Geoffrey Liu; Meredith E Giuliani Journal: J Oncol Pract Date: 2018-04-20 Impact factor: 3.840
Authors: N Gudzenko; M Hatch; D Bazyka; I Dyagil; R F Reiss; A Brenner; V Chumak; N Babkina; L B Zablotska; K Mabuchi Journal: Environ Res Date: 2015-06-24 Impact factor: 6.498
Authors: Timothy Styles; Manxia Wu; Reda Wilson; Frances Babcock; David Butterworth; Dee W West; Lisa C Richardson Journal: J Registry Manag Date: 2016
Authors: M Shayne Gallaway; S Jane Henley; C Brooke Steele; Behnoosh Momin; Cheryll C Thomas; Ahmed Jamal; Katrina F Trivers; Simple D Singh; Sherri L Stewart Journal: MMWR Surveill Summ Date: 2018-11-02
Authors: Marisa J L Aitken; Christopher B Benton; Ghayas C Issa; Koji Sasaki; Musa Yilmaz; Nicholas J Short Journal: Acta Haematol Date: 2021-03-18 Impact factor: 2.195
Authors: Antonio J Neri; Behnoosh R Momin; Trevor D Thompson; Jennifer Kahende; Lei Zhang; Mary C Puckett; Sherri L Stewart Journal: Cancer Date: 2016-02-08 Impact factor: 6.921